Kevin M. Slawin, Chief Technology Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 23,216 shares at $20.12 ($467K) on 2016-09-23, disclosed to the SEC on 2016-09-23.
Open-market sale of $467k BLCM by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.11 | 11,958 | $240K | 51.5% |
| 2 | $20.12 | 11,258 | $227K | 48.5% |
| Total | $20.11 avg | 23,216 | $467K | 100% |
| Filing → |
| BLCM | SELL | 2016-09-23 | $936K | — | Filing → |
| BLCM | SELL | 2016-09-23 | $240K | — | Filing → |
| BLCM | SELL | 2016-09-20 | $92K | — | Filing → |